Genotype, In-Vivo, Licensing and Trials - Clinical Research Informer

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Genotype

In-Vivo

Licensing

Trials

10 Key Learnings from Successful Cellular and Gene Therapy Trials for Rare Diseases

XTalks

APRIL 24, 2023

Rare disease clinical trials are complex due to the additional scientific, medical, operational and regulatory requirements of newly emerging advanced therapies, such as gene therapy,” says Dr. “Thankfully, we can anticipate that many more of these new treatments are expected in the future.”

Gene Therapy

Gene Therapy Gene Trials Clinical Trials

Global Roundup: Overland Pharma Launches in China to Provide Access to Breakthrough Therapies

The Pharma Data

DECEMBER 9, 2020

The Chinese biopharmaceutical industry is growing in leaps and bounds, but there is still a huge unmet need when it comes to getting patients access to the breakthrough therapeutic modalities and platforms like RNAi, cell and gene therapy and others. A solution could be at hand with Overland Pharmaceuticals.

In-Vivo

In-Vivo In-Vitro Antibody Development

10 Key Learnings from Successful Cellular and Gene Therapy Trials for Rare Diseases

Global Roundup: Overland Pharma Launches in China to Provide Access to Breakthrough Therapies

Stay Connected